At DermaVue, every patient undergoes a full metabolic evaluation including thyroid function, kidney function, liver panel, and HbA1c before semaglutide is prescribed
No, diarrhea does not indicate treatment failure
This is the point where FSH, LH, estradiol, and thyroid markers give you the data to make an informed decision about whether to continue escalating, hold your dose, or modify your caloric intake to reduce the metabolic stress signal to the hypothalamic-pituitary-ovarian axis
As with any medication, the decision to start a GLP-1 should be individualized
Unauthorised or falsified medicinal products carry considerable risks particularly if they contain undeclared substances, impurities or incorrect doses